1. Home
  2. CTKB vs SLDB Comparison

CTKB vs SLDB Comparison

Compare CTKB & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • SLDB
  • Stock Information
  • Founded
  • CTKB 1990
  • SLDB 2013
  • Country
  • CTKB United States
  • SLDB United States
  • Employees
  • CTKB N/A
  • SLDB N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CTKB Health Care
  • SLDB Health Care
  • Exchange
  • CTKB Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • CTKB 526.7M
  • SLDB 433.0M
  • IPO Year
  • CTKB 2021
  • SLDB 2018
  • Fundamental
  • Price
  • CTKB $3.92
  • SLDB $5.47
  • Analyst Decision
  • CTKB Hold
  • SLDB Strong Buy
  • Analyst Count
  • CTKB 4
  • SLDB 10
  • Target Price
  • CTKB $6.00
  • SLDB $15.00
  • AVG Volume (30 Days)
  • CTKB 932.3K
  • SLDB 742.4K
  • Earning Date
  • CTKB 11-04-2025
  • SLDB 11-05-2025
  • Dividend Yield
  • CTKB N/A
  • SLDB N/A
  • EPS Growth
  • CTKB N/A
  • SLDB N/A
  • EPS
  • CTKB N/A
  • SLDB N/A
  • Revenue
  • CTKB $196,035,000.00
  • SLDB N/A
  • Revenue This Year
  • CTKB $0.09
  • SLDB N/A
  • Revenue Next Year
  • CTKB $7.45
  • SLDB N/A
  • P/E Ratio
  • CTKB N/A
  • SLDB N/A
  • Revenue Growth
  • CTKB N/A
  • SLDB N/A
  • 52 Week Low
  • CTKB $2.37
  • SLDB $2.41
  • 52 Week High
  • CTKB $7.63
  • SLDB $8.10
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 49.11
  • SLDB 46.65
  • Support Level
  • CTKB $3.80
  • SLDB $4.87
  • Resistance Level
  • CTKB $4.14
  • SLDB $5.69
  • Average True Range (ATR)
  • CTKB 0.21
  • SLDB 0.32
  • MACD
  • CTKB -0.03
  • SLDB 0.01
  • Stochastic Oscillator
  • CTKB 41.24
  • SLDB 64.71

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: